Stockreport

Rallybio to acquire Candid Therapeutics [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF US-based biotechnology company Rallybio has entered a definitive agreement to acquire Candid Therapeutics through a merger transaction. Following completion, the comb [Read more]